181 related articles for article (PubMed ID: 24362271)
41. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
Gebauer G; Rieger M; Jäger W; Lang N
Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
[TBL] [Abstract][Full Text] [Related]
42. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model.
Andjelić B; Todorović-Balint M; Antić D; Bila J; Djurašinović V; Mihaljević B
Vojnosanit Pregl; 2015 Jan; 72(1):26-32. PubMed ID: 26043587
[TBL] [Abstract][Full Text] [Related]
43. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
Kitai R; Sasaki H; Matsuda K; Tsunetoshi K; Yamauchi T; Neishi H; Matsumura K; Tsunoda A; Takeuchi H; Sato K; Kikuta K
Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
[TBL] [Abstract][Full Text] [Related]
44. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.
Mihaljevic B; Jelicic J; Andjelic B; Antic D; Markovic O; Petkovic I; Jovanovic MP; Trajkovic G; Bila J; Djurasinovic V; Sretenovic A; Vukovic V; Smiljanic M; Balint MT
Int J Hematol; 2016 Dec; 104(6):692-699. PubMed ID: 27714586
[TBL] [Abstract][Full Text] [Related]
45. Assessment of prognostic factors in follicular lymphoma patients.
Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y
Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204
[TBL] [Abstract][Full Text] [Related]
46. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
Wakao D; Murohashi I; Tominaga K; Yoshida K; Kishimoto K; Yagasaki F; Itoh Y; Itoh K; Sakata T; Kawai N; Kayano H; Suzuki T; Matsuda A; Hirashima K; Bessho M
Ann Hematol; 2002 Mar; 81(3):140-6. PubMed ID: 11904739
[TBL] [Abstract][Full Text] [Related]
47. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
48. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
49. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
50. Rapidly progressed primary intestinal follicular lymphoma with elevation of soluble interleukin-2 receptor levels.
Iwamuro M; Takenaka R; Mori A; Fujiki S; Miyake T; Asakura S; Okada H; Takata K; Yoshino T; Yamamoto K
Case Rep Oncol Med; 2014; 2014():549248. PubMed ID: 24876980
[TBL] [Abstract][Full Text] [Related]
51. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.
Wagner DK; Kiwanuka J; Edwards BK; Rubin LA; Nelson DL; Magrath IT
J Clin Oncol; 1987 Aug; 5(8):1262-74. PubMed ID: 3114436
[TBL] [Abstract][Full Text] [Related]
52. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
[TBL] [Abstract][Full Text] [Related]
54. Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma.
Hirami Y; Nishimura MF; Urata T; Morimoto M; Maekawa Y; Yoshino T; Nishimura Y; Sato Y
J Clin Exp Hematop; 2023 Mar; 63(1):25-31. PubMed ID: 36843068
[TBL] [Abstract][Full Text] [Related]
55. Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
Sonbol MB; Maurer MJ; Stenson MJ; Allmer C; LaPlant BR; Weiner GJ; Macon WR; Cerhan JR; Witzig TE; Gupta M
Am J Hematol; 2014 Dec; 89(12):E223-7. PubMed ID: 25164110
[TBL] [Abstract][Full Text] [Related]
56. [The relation between clinical features of adult T-cell leukemia/lymphoma and the serum levels of soluble CD25 and CD30].
Takemoto S; Pornkuna R; Hidaka M; Kawano F
Rinsho Ketsueki; 2016 Jul; 57(7):848-53. PubMed ID: 27498727
[TBL] [Abstract][Full Text] [Related]
57. The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?
Denham JW; Denham E; Dear KB; Hudson GV
Eur J Cancer; 1996 Mar; 32A(3):480-90. PubMed ID: 8814696
[TBL] [Abstract][Full Text] [Related]
58. Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems.
Perea G; Altés A; Montoto S; López-Guillermo A; Domingo-Doménech E; Fernández-Sevilla A; Ribera JM; Grau J; Pedro C; Angel Hernández J; Estany C; Briones J; Martino R; Sureda A; Sierra J; Montserrat E
Ann Oncol; 2005 Sep; 16(9):1508-13. PubMed ID: 15939718
[TBL] [Abstract][Full Text] [Related]
59. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract][Full Text] [Related]
60. Clinical factors indicating the presence of malignant lymphoma before lymph node dissection.
Okumura Y; Nomura K; Kikuchi T; Suzuki T; Hidaka H; Ogawa T; Katori Y
Acta Otolaryngol; 2015 May; 135(5):513-8. PubMed ID: 25719957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
